The changing shape of large company investment engagement in Australia
Tracks
Track 1
Track 2
Track 3
Thursday, October 31, 2024 |
9:00 AM - 10:00 AM |
Details
The shape of large pharma and medtech investment in Australia has been changing for time but has government and industry caught up? Recent investments by both Australian anchors and large global players shows that on shore commercialised research, enhanced manufacturing capability, and new partnerships are possible in Australia and can hold powerful promise to boost our biotech ecosystem, but harnessing the power of these investments requires a different mindset for engagement both from government and industry. So, what do our biggest players really want? And how can supporting new investment benefit SMEs and service providers seeking to scale up and out?
Speaker
Rebekah Cassidy
Chief Executive Officer
AusBiotech
Chair
Joy Linton
Chief Financial Officer
CSL